JP2023504795A5 - - Google Patents

Info

Publication number
JP2023504795A5
JP2023504795A5 JP2022531434A JP2022531434A JP2023504795A5 JP 2023504795 A5 JP2023504795 A5 JP 2023504795A5 JP 2022531434 A JP2022531434 A JP 2022531434A JP 2022531434 A JP2022531434 A JP 2022531434A JP 2023504795 A5 JP2023504795 A5 JP 2023504795A5
Authority
JP
Japan
Application number
JP2022531434A
Other languages
Japanese (ja)
Other versions
JP2023504795A (ja
JP7808032B2 (ja
JPWO2021105317A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/083566 external-priority patent/WO2021105317A1/en
Publication of JP2023504795A publication Critical patent/JP2023504795A/ja
Publication of JP2023504795A5 publication Critical patent/JP2023504795A5/ja
Publication of JPWO2021105317A5 publication Critical patent/JPWO2021105317A5/ja
Priority to JP2025116497A priority Critical patent/JP2025163046A/ja
Application granted granted Critical
Publication of JP7808032B2 publication Critical patent/JP7808032B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022531434A 2019-11-28 2020-11-27 トランスフォーミング増殖因子-β受容体I/ALK5の阻害剤としてのベンジルアミド誘導体 Active JP7808032B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025116497A JP2025163046A (ja) 2019-11-28 2025-07-10 トランスフォーミング増殖因子-β受容体I/ALK5の阻害剤としてのベンジルアミド誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19383057.7 2019-11-28
EP19383057 2019-11-28
PCT/EP2020/083566 WO2021105317A1 (en) 2019-11-28 2020-11-27 Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025116497A Division JP2025163046A (ja) 2019-11-28 2025-07-10 トランスフォーミング増殖因子-β受容体I/ALK5の阻害剤としてのベンジルアミド誘導体

Publications (4)

Publication Number Publication Date
JP2023504795A JP2023504795A (ja) 2023-02-07
JP2023504795A5 true JP2023504795A5 (https=) 2023-12-06
JPWO2021105317A5 JPWO2021105317A5 (https=) 2023-12-06
JP7808032B2 JP7808032B2 (ja) 2026-01-28

Family

ID=68808255

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022531434A Active JP7808032B2 (ja) 2019-11-28 2020-11-27 トランスフォーミング増殖因子-β受容体I/ALK5の阻害剤としてのベンジルアミド誘導体
JP2025116497A Pending JP2025163046A (ja) 2019-11-28 2025-07-10 トランスフォーミング増殖因子-β受容体I/ALK5の阻害剤としてのベンジルアミド誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025116497A Pending JP2025163046A (ja) 2019-11-28 2025-07-10 トランスフォーミング増殖因子-β受容体I/ALK5の阻害剤としてのベンジルアミド誘導体

Country Status (16)

Country Link
US (2) US12297186B2 (https=)
EP (1) EP4065572A1 (https=)
JP (2) JP7808032B2 (https=)
KR (1) KR20220107180A (https=)
CN (1) CN114787145B (https=)
AR (1) AR120578A1 (https=)
AU (1) AU2020394531A1 (https=)
BR (1) BR112022010251A2 (https=)
CA (1) CA3160963A1 (https=)
ES (1) ES3029608T1 (https=)
IL (1) IL293388B2 (https=)
MX (1) MX2022005843A (https=)
PH (1) PH12022551177A1 (https=)
SA (1) SA522432749B1 (https=)
WO (1) WO2021105317A1 (https=)
ZA (1) ZA202205149B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3978487A1 (en) 2020-09-30 2022-04-06 Origo Biopharma, S.L. 2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5
TW202543626A (zh) 2024-02-22 2025-11-16 西班牙商亞哥邁伯西班牙有限公司 新穎結晶相形式

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3621540A1 (de) 1986-06-27 1988-01-07 Basf Ag Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von bakterien und pilzen
JP2004521915A (ja) * 2001-02-02 2004-07-22 グラクソ グループ リミテッド Tgf過剰発現に対するピラゾール誘導体
HRP20050247A2 (en) 2002-09-18 2005-10-31 Pfizer Products Inc. Pyrazole derivatives as transforming growth factor (tgf) inhibitors
WO2004026302A1 (en) * 2002-09-19 2004-04-01 Eli Lilly And Company Methods of inhibiting tgf beta with substituted pyrazoles
CL2004000234A1 (es) * 2003-02-12 2005-04-15 Biogen Idec Inc Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
CN102056907B (zh) 2008-04-04 2014-12-31 武田药品工业株式会社 杂环衍生物及其用途
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
AR079545A1 (es) 2009-12-21 2012-02-01 Bayer Cropscience Ag Tienilpiri(mi)dinilazol
DK2731949T3 (en) * 2011-07-13 2018-06-14 Tiumbio Co Ltd 2-PYRIDYL-SUBSTITUTED IMIDAZOLS AS ALK5 AND / OR ALK4 INHIBITORS
US11021468B2 (en) * 2015-04-01 2021-06-01 Rigel Pharmaceuticals, Inc. TGF-ß inhibitors
WO2016172631A2 (en) 2015-04-24 2016-10-27 President And Fellows Of Harvard College Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
KR102434226B1 (ko) * 2016-06-30 2022-08-19 한미약품 주식회사 Alk5 억제제로서의 신규 피라졸 유도체 및 이의 용도
JP2021518855A (ja) 2018-03-02 2021-08-05 ユニヴェルシテ ド ローザンヌ Wntシグナル伝達経路阻害剤としてのピラゾール誘導体
US11945803B2 (en) 2018-08-07 2024-04-02 Tosk, Inc. Modulators of RAS GTPase
CN110433164A (zh) * 2019-08-15 2019-11-12 南开大学 TGF-beta受体分子抑制剂在治疗小鼠动物模型中急性髓系白血病的应用
EP3978487A1 (en) 2020-09-30 2022-04-06 Origo Biopharma, S.L. 2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5

Similar Documents

Publication Publication Date Title
JP2023504795A5 (https=)
CN305527112S (https=)
CN306297726S (https=)
CN305836058S (https=)
CN305536452S (https=)
CN305536190S (https=)
CN305536169S (https=)
CN305835724S (https=)
CN305536097S (https=)
CN305536025S (https=)
CN305835419S (https=)
CN305535959S (https=)
CN305975377S (https=)
CN305535813S (https=)
CN305825263S (https=)
CN305533708S (https=)
CN305533500S (https=)
CN306213748S (https=)
CN305803355S (https=)
CN305722204S (https=)
CN305720061S (https=)
CN305531760S (https=)
CN305527893S (https=)
CN305527567S (https=)
CN306214167S (https=)